Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elvin Koh

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biotechnology Journal|March 17, 2020
Biotherapeutic Approaches in Atopic DermatitisElizabeth Huiwen Tham, Elvin Koh, John E A Common, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 25, 2016
Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteriaIn Young Hwang, Elvin Koh, Hye Rim Kim, et al.
ACS Synthetic Biology|September 12, 2013
Reprogramming microbes to be pathogen-seeking killersIn Young Hwang, Mui Hua Tan, Elvin Koh, et al.
Nature Communications|April 12, 2017
Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal modelsIn Young Hwang, Elvin Koh, Adison Wong, et al.
Plos Biology|April 6, 2012
Mediator acts upstream of the transcriptional activator Gal4Keven Ang, Gary Ee, Edwin Ang, et al.
Nature Communications|July 5, 2022
Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolismElvin Koh, In Young Hwang, Hui Ling Lee, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biotechnology Journal|March 17, 2020
Biotherapeutic Approaches in Atopic DermatitisElizabeth Huiwen Tham, Elvin Koh, John E A Common, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 25, 2016
Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteriaIn Young Hwang, Elvin Koh, Hye Rim Kim, et al.
ACS Synthetic Biology|September 12, 2013
Reprogramming microbes to be pathogen-seeking killersIn Young Hwang, Mui Hua Tan, Elvin Koh, et al.
Nature Communications|April 12, 2017
Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal modelsIn Young Hwang, Elvin Koh, Adison Wong, et al.
Plos Biology|April 6, 2012
Mediator acts upstream of the transcriptional activator Gal4Keven Ang, Gary Ee, Edwin Ang, et al.
Nature Communications|July 5, 2022
Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolismElvin Koh, In Young Hwang, Hui Ling Lee, et al.
Pageof 1